Association Between Helicobacter Pylori Infection and Body Mass Index, Before and After Eradication of Infection in Hemodialysis Batients

Overview

Journal J Nephropathol

Specialty Nephrology

Date 2014 Jan 30

PMID 24475411

Citations 10

Authors

Mojgan Jalalzadeh

Mohammad Hassan Ghadiani

Nouraddin Mousavinasab

Affiliations

Soon will be listed here.

Abstract

Background: In dialysis patients, chronic infections have been associated with cachexia and anorexia.

Objectives: This study was carried out to determine the association between Helicobacter pylori (HP) infection and body mass index (BMI) in hemodialysis (HD) patients.

Patients And Methods: Ninety eight patients were divided into two groups of negative (group 1) and positive (group 2), for HP. BMI of all patients was measured at the beginning and in group2 after six months following eradication of HP. Before dialysis, various paraclinical parameters were checked at the same intervals.

Results: Fifty-nine patients were enrolled in group 1 and 39 patients in group 2. The means of BMI in groups 1 and 2 were 23.4±3.7 and 25.8±4.4kg/m², respectively. Prior to the study, there was no significant difference for BMI, duration of HD and paraclinic data between two groups. Group 2 took anti HP therapy and eradication occurred in 30 of them. In this group six months after eradication of HP, the BMI was significantly decreased from 25.02±4.4 to 24.4±4.0 kg/m² (P = 0.001). Also six months following the eradication of HP, the mean of serum albumin level was significantly declined from 4.2 to 3.7 g/L (P<0.001). There was also significant decrease in cholesterol (P=0.001), blood urea nitrogen (P=0.005) and calcium (P=0.02). However, significant increase in hemoglobin level was also seen (P=0.03).

Conclusions: The results of this study show that eradication of HP has an impact on BMI. The results need to be investigated with larger cases.

Citing Articles

Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.

Kountouras J, Papaefthymiou A, Polyzos S, Kazakos E, Vardaka E, Touloumtzi M Arq Bras Cardiol. 2022; 119(3):502-504.

PMID: 36074383 PMC: 9438526. DOI: 10.36660/abc.20210931.

Kountouras J, Papaefthymiou A, Polyzos S, Deretzi G, Vardaka E, Soteriades E Microorganisms. 2021; 9(11).

PMID: 34835476 PMC: 8618184. DOI: 10.3390/microorganisms9112351.

Relationship Between Infection and Arteriosclerosis.

Furuto Y, Kawamura M, Yamashita J, Yoshikawa T, Namikawa A, Isshiki R Int J Gen Med. 2021; 14:1533-1540.

PMID: 33935515 PMC: 8079247. DOI: 10.2147/IJGM.S303071.

Nutrition status and infection in patients receiving hemodialysis.

Sugimoto M, Yasuda H, Andoh A World J Gastroenterol. 2018; 24(15):1591-1600.

PMID: 29686466 PMC: 5910542. DOI: 10.3748/wjg.v24.i15.1591.

Medicinal Plants, Effective Plant Compounds (Compositions) and their Effects on Stomach Cancer.

Aleebrahim-Dehkordy E, Nasri H, Baradaran A, Nasri P, Tamadon M, Hedaiaty M Int J Prev Med. 2017; 8:96.

PMID: 29184647 PMC: 5686923. DOI: 10.4103/ijpvm.IJPVM_4_17.

References

Kalantar-Zadeh K, Kopple J . Obesity paradox in patients on maintenance dialysis. Contrib Nephrol. 2006; 151:57-69. DOI: 10.1159/000095319. View

Park S, Jeon W, Kim S, Kim H, Park D, Cho Y . Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005; 97(4):508-13. PMC: 2568737. View

Sezer S, Ibis A, Ozdemir B, Ozdemir F, Kulah E, Boyacioglu S . Association of helicobacter pylori infection with nutritional status in hemodialysis patients. Transplant Proc. 2004; 36(1):47-9. DOI: 10.1016/j.transproceed.2003.11.023. View

Strid H, Simren M, Johansson A, Svedlund J, Samuelsson O, Bjornsson E . The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant. 2002; 17(8):1434-9. DOI: 10.1093/ndt/17.8.1434. View

Genta R . The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis. 1997; 8(1):2-11. View

Molnar M, Streja E, Kovesdy C, Bunnapradist S, Sampaio M, Jing J . Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant. 2011; 11(4):725-36. PMC: 3074356. DOI: 10.1111/j.1600-6143.2011.03468.x. View

Sung J, Sanderson J . Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart. 1996; 76(4):305-7. PMC: 484538. DOI: 10.1136/hrt.76.4.305. View

Moss S, Legon S, Davies J, Calam J . Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994; 35(11):1567-70. PMC: 1375613. DOI: 10.1136/gut.35.11.1567. View

Torun D, Micozkadioglu H, Torun N, Ozelsancak R, Sezer S, Adam F . Increased body mass index is not a reliable marker of good nutrition in hemodialysis patients. Ren Fail. 2007; 29(4):487-93. DOI: 10.1080/08860220701274959. View

10.

Nardone G, Rocco A, Fiorillo M, Del Pezzo M, Autiero G, Cuomo R . Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter. 2005; 10(1):53-8. DOI: 10.1111/j.1523-5378.2005.00291.x. View

11.

Falaknazi K, Jalalzadeh M, Vafaeimanesh J . Noninvasive stool antigen assay for screening of Helicobacter pylori infection and assessing success of eradication therapy in patients on hemodialysis. Iran J Kidney Dis. 2010; 4(4):317-21. View

12.

Heitmann B, ERIKSON H, Ellsinger B, Mikkelsen K, Larsson B . Mortality associated with body fat, fat-free mass and body mass index among 60-year-old swedish men-a 22-year follow-up. The study of men born in 1913. Int J Obes Relat Metab Disord. 2000; 24(1):33-7. DOI: 10.1038/sj.ijo.0801082. View

13.

Jalalzadeh M, Saber H, Vafaeimanesh J, Mirzamohammadi F, Falaknazi K . Association of Helicobacter pylori infection and serum albumin in patients on hemodialysis. Iran J Kidney Dis. 2010; 4(4):312-6. View

14.

Kalantar-Zadeh K, Kuwae N, Wu D, Shantouf R, Fouque D, Anker S . Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83(2):202-10. DOI: 10.1093/ajcn/83.2.202. View

15.

Soubassi L, Papadakis E, Theodoropoulos I, Poulos G, Chaniotis D, Tsapakidis I . Incidence and risk factors of coronary artery disease in patients on chronic hemodialysis. Int J Artif Organs. 2007; 30(3):253-7. DOI: 10.1177/039139880703000311. View

16.

Mafra D, Elias Farage N, Azevedo D, Viana G, Mattos J, Velarde L . Impact of serum albumin and body-mass index on survival in hemodialysis patients. Int Urol Nephrol. 2007; 39(2):619-24. DOI: 10.1007/s11255-007-9201-2. View

17.

Kalantar-Zadeh K, Kilpatrick R, Kuwae N, McAllister C, Alcorn Jr H, Kopple J . Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005; 20(9):1880-8. DOI: 10.1093/ndt/gfh941. View

18.

Majchrzak K, Pupim L, Sundell M, Ikizler T . Body composition and physical activity in end-stage renal disease. J Ren Nutr. 2007; 17(3):196-204. PMC: 2746570. DOI: 10.1053/j.jrn.2007.01.003. View

19.

Stenvinkel P, Heimburger O, Lindholm B, Kaysen G, Bergstrom J . Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000; 15(7):953-60. DOI: 10.1093/ndt/15.7.953. View

20.

Furuta T, Shirai N, Xiao F, Takashima M, Hanai H . Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002; 16(4):799-806. DOI: 10.1046/j.1365-2036.2002.01222.x. View